Gábor Orbán
Gábor Orbán is the CEO of Richter Gedeon Nyrt., a major Hungarian pharmaceutical company. Under his leadership, the company has been focusing on enhancing its internal capabilities and expanding its market presence. Recently, he announced the company's new long-term strategy, aiming to improve the quality of life for patients, particularly in women's health and neuropsychiatry, by 2035. Orbán emphasized the importance of aligning market trends with the company's strengths and highlighted the significant growth and profitability improvements achieved over the past few years.
Not in the pool (under ¢1).
Recent news mentions
Gábor Orbán, the chairman of the foundation maintaining the university, highlighted the dual nature of the medical graduation as both an end and a beginning.
Index - Belföld - Olyan orvosgeneráció végzett most a Semmelweis Egyetemen, amihez hasonlót keresve sem találunk
Hungary· 2026-07-04
Gábor Orbán, the CEO of MVM ONEnergy, stated that the merger broadens the company's portfolio and increases its market weight.
Index - Gazdaság - Új néven folytatja tevékenységét Magyarország legnagyobb energiakereskedőjeHungary· 2025-11-04
Gábor Orbán is the CEO of Richter, who provided detailed answers to questions earlier this year.
Index - Gazdaság - Óriási változás jöhet a gyógyszereknél – sejtelmes bejegyzést publikált az egyik kormánytagHungary· 2025-05-19
Gábor Orbán, the CEO of Richter, discussed the company's new strategy and its focus on improving efficiency and market trends.
Index - Gazdaság - Bejelentést tett a Richter, új korszak kezdődik a gyógyszergyártásbanHungary· 2025-03-05